Emsam and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Emsam (selegiline), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ibuprofen, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Drowsiness when taking Emsam. It is created by eHealthMe based on reports of 1,646 people who have side effects when taking Emsam from the FDA, and is updated regularly.

What is Emsam?

Emsam has active ingredients of selegiline. It is often used in depression. eHealthMe is studying from 1,875 Emsam users. Check the latest studies of Emsam.

What is Drowsiness?

Drowsiness is found to be associated with 2,863 drugs and 4,800 conditions by eHealthMe. Check the latest studies of Drowsiness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 08, 2026

1,646 people reported to have side effects when taking Emsam.
Among them, 39 people (2.37%) have Drowsiness.

Among these 39 people:

How long have people been on Emsam when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Emsam? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Drowsiness when taking Emsam? *

What are other drugs people take besides Emsam? *

Zopiclone: 8 people, 20.51%
Melatonin: 8 people, 20.51%
Ibuprofen: 8 people, 20.51%
Xyrem: 6 people, 15.38%
Klonopin: 5 people, 12.82%
Alprazolam: 4 people, 10.26%
Metformin Hydrochloride: 4 people, 10.26%
Metformin: 4 people, 10.26%
Omeprazole: 4 people, 10.26%
Fish Oil: 4 people, 10.26%

What are other side effects people have besides Drowsiness? *

Confusional State: 11 people, 28.21%
Drug Ineffective: 9 people, 23.08%
Speech Impairment (Adult) (inability to speak (adult)): 9 people, 23.08%
Fatigue (feeling of tiredness): 9 people, 23.08%
Feeling Abnormal: 8 people, 20.51%
Insomnia (sleeplessness): 8 people, 20.51%
Stress And Anxiety: 7 people, 17.95%
Headache (pain in head): 6 people, 15.38%
Weight Increased: 6 people, 15.38%
Crying: 5 people, 12.82%

What are the existing conditions these people have? *

Toothaches (tooth pain): 8 people, 20.51%
Stress And Anxiety: 8 people, 20.51%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 12.82%
Insomnia (sleeplessness): 5 people, 12.82%
High Blood Pressure: 5 people, 12.82%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.26%
Bipolar Disorder (mood disorder): 3 people, 7.69%
Pain: 3 people, 7.69%
Sleep Disorder: 2 people, 5.13%
High Blood Cholesterol: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Emsam and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emsam:

Emsam (1,875 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Emsam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,863 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,800 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on selegiline (the active ingredients of Emsam) and Emsam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.